Literature DB >> 15066753

"Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.

Elias Fattal1, Patrick Couvreur, Catherine Dubernet.   

Abstract

Antisense oligonucleotides are molecules that are able to inhibit gene expression being, therefore, potentially active for the treatment of viral infections cancer or inflammatory diseases. However, because of their poor stability in biological medium and their weak intracellular penetration, "smart" delivery systems such as anionic pH-sensitive liposomes were designed. Most known liposome formulations contain a specific phospholipid, phosphatidylethanolamine (PE), which undergoes a transition from lamellar to inverted micelles structures at low pH and allow fusion of liposomal and endosomal membranes and by consequence destabilization of the endosomes. Therefore, liposomes made of PE are able to release their contents in response to acidic pH within the endosomal system while remaining stable in plasma thus improving the cytoplasmic delivery of oligonucleotides after endocytosis. This review illustrates the advantages of this approach for the delivery of antisense oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066753     DOI: 10.1016/j.addr.2003.10.037

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  30 in total

1.  Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug.

Authors:  Hongtao Xu; James W Paxton; Zimei Wu
Journal:  Pharm Res       Date:  2015-02-06       Impact factor: 4.200

2.  Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents.

Authors:  Volker Mailänder; Myriam Ricarda Lorenz; Verena Holzapfel; Anna Musyanovych; Karin Fuchs; Markus Wiesneth; Paul Walther; Katharina Landfester; Hubert Schrezenmeier
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

3.  Maximization of loading and stability of ssDNA:iron oxide nanoparticle complexes formed through electrostatic interaction.

Authors:  Lorenzo Berti; Temesgen Woldeyesus; Yuanpei Li; Kit S Lam
Journal:  Langmuir       Date:  2010-11-03       Impact factor: 3.882

4.  Redox-triggered contents release from liposomes.

Authors:  Winston Ong; Yuming Yang; Angela C Cruciano; Robin L McCarley
Journal:  J Am Chem Soc       Date:  2008-10-08       Impact factor: 15.419

5.  pHLIP®-mediated delivery of PEGylated liposomes to cancer cells.

Authors:  Lan Yao; Jennifer Daniels; Dayanjali Wijesinghe; Oleg A Andreev; Yana K Reshetnyak
Journal:  J Control Release       Date:  2013-02-15       Impact factor: 9.776

6.  Influence of cholesterol on liposome stability and on in vitro drug release.

Authors:  Maria-Lucia Briuglia; Chiara Rotella; Amber McFarlane; Dimitrios A Lamprou
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

7.  Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells.

Authors:  Hongtao Xu; James W Paxton; Zimei Wu
Journal:  Pharm Res       Date:  2016-03-10       Impact factor: 4.200

8.  Cellular delivery and biological activity of antisense oligonucleotides conjugated to a targeted protein carrier.

Authors:  Hyunmin Kang; Md Rowshon Alam; Vidula Dixit; Michael Fisher; Rudy L Juliano
Journal:  Bioconjug Chem       Date:  2008-11-19       Impact factor: 4.774

9.  Thermally gated liposomes: a closer look.

Authors:  Ravil R Petrov; Wen-Hua Chen; Steven L Regen
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

10.  Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia.

Authors:  Yan Jin; Shujun Liu; Bo Yu; Sharon Golan; Chee-Guan Koh; Jintao Yang; Lenguyen Huynh; Xiaojuan Yang; Jiuxia Pang; Natarajan Muthusamy; Kenneth K Chan; John C Byrd; Yeshayahu Talmon; L James Lee; Robert J Lee; Guido Marcucci
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.